Skip to main content
SpringerLink
Log in
Book cover

Chronic Kidney Disease pp 57–69Cite as

Pregnancy in Chronic Kidney Disease

  • Chapter
  • First Online:

  • 1995 Accesses

Abstract

Although the pregnancy rate of women with chronic kidney disease (CKD) and the overall survival rate of their fetuses have improved, pregnancy in women with CKD still have a high risk of adverse maternal and fetal outcomes. To achieve better outcomes for this particular population, managing pregnancy in women with CKD has become a considerable challenge shared by both nephrologists and obstetricians. Strengthened management, including prepregnancy preparation, pregnancy management, peripartum management, and postpartum care, could prevent or mitigate maternal renal damage and adverse maternal and fetal outcomes. Women with CKD require risk assessment of pregnancy before conceiving, close follow-up by both nephrologists and obstetricians to monitor disease activity and detect obstetric complications during pregnancy, evaluation of indications for termination of pregnancy and selection of delivery mode, and assessment of disease activity and emotional support to prevent depression after delivery.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Hladunewich MA, et al. Managing glomerular disease in pregnancy. Nephrol Dial Transplant. 2017;32(suppl_1):i48–56.

    Article  CAS  Google Scholar 

  2. Park S, et al. Midterm eGFR and adverse pregnancy outcomes: the clinical significance of gestational hyperfiltration. Clin J Am Soc Nephrol. 2017;12(7):1048–56.

    Article  Google Scholar 

  3. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.

    Google Scholar 

  4. Levey AS, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67(6):2089–100.

    Article  Google Scholar 

  5. Levey AS, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130(6):461–70.

    Article  CAS  Google Scholar 

  6. Levey AS, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.

    Article  Google Scholar 

  7. Hladunewich MA. Chronic kidney disease and pregnancy. Semin Nephrol. 2017;37(4):337–46.

    Article  Google Scholar 

  8. Piccoli GB, et al. Risk of adverse pregnancy outcomes in women with CKD. J Am Soc Nephrol. 2015;26(8):2011–22.

    Article  Google Scholar 

  9. Piccoli GB, et al. Hypertension in CKD pregnancy: a question of cause and effect (cause or effect? This is the question). Curr Hypertens Rep. 2016;18(5):35.

    Article  Google Scholar 

  10. Bramham K, et al. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014;348:g2301.

    Article  Google Scholar 

  11. Barbour SJ, et al. Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int. 2012;81(2):190–5.

    Article  Google Scholar 

  12. Hladunewich MA, Melamad N, Bramham K. Pregnancy across the spectrum of chronic kidney disease. Kidney Int. 2016;89(5):995–1007.

    Article  Google Scholar 

  13. Blom K, et al. Pregnancy and glomerular disease: a systematic review of the literature with management guidelines. Clin J Am Soc Nephrol. 2017;12(11):1862–72.

    Article  CAS  Google Scholar 

  14. Buyon JP, et al. Kidney outcomes and risk factors for nephritis (flare/De novo) in a multiethnic cohort of pregnant patients with lupus. Clin J Am Soc Nephrol. 2017;12(6):940–6.

    Article  CAS  Google Scholar 

  15. Alkhunaizi A, Melamed N, Hladunewich MA. Pregnancy in advanced chronic kidney disease and end-stage renal disease. Curr Opin Nephrol Hypertens. 2015;24(3):252–9.

    Article  CAS  Google Scholar 

  16. Wyld ML, et al. Pregnancy outcomes for kidney transplant recipients. Am J Transplant. 2013;13(12):3173–82.

    Article  CAS  Google Scholar 

  17. Deshpande NA, et al. Pregnancy outcomes in kidney transplant recipients: a systematic review and meta-analysis. Am J Transplant. 2011;11(11):2388–404.

    Article  CAS  Google Scholar 

  18. Transplantation EEGoR. European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipients. Nephrol Dial Transplant. 2002;17(Suppl 4):50–5.

    Google Scholar 

  19. McKay DB, et al. Reproduction and transplantation: report on the AST consensus conference on reproductive issues and transplantation. Am J Transplant. 2005;5(7):1592–9.

    Article  Google Scholar 

  20. Lidegaard O, et al. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med. 2012;366(24):2257–66.

    Article  CAS  Google Scholar 

  21. Bailie GR, et al. Sexual dysfunction in dialysis patients treated with antihypertensive or antidepressive medications: results from the DOPPS. Nephrol Dial Transplant. 2007;22(4):1163–70.

    Article  CAS  Google Scholar 

  22. Mok CC, et al. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide. Am J Med. 2006;119(4):355 e25–33.

    Article  Google Scholar 

  23. Diav-Citrin O, et al. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers. Reprod Toxicol. 2011;31(4):540–5.

    Article  CAS  Google Scholar 

  24. Murphy KE, et al. Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet. 2008;372(9656):2143–51.

    Article  CAS  Google Scholar 

  25. Clowse ME, et al. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 2006;54(11):3640–7.

    Article  Google Scholar 

  26. Coscia LA, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl. 2010:65–85.

    Google Scholar 

  27. Kim H, et al. The optimal therapy of calcineurin inhibitors for pregnancy in kidney transplantation. Clin Transpl. 2015;29(2):142–8.

    Article  CAS  Google Scholar 

  28. Zheng S, et al. Pharmacokinetics of tacrolimus during pregnancy. Ther Drug Monit. 2012;34(6):660–70.

    Article  CAS  Google Scholar 

  29. Ostensen M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006;8(3):209.

    Article  Google Scholar 

  30. Chakravarty EF, et al. Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011;117(5):1499–506.

    Article  CAS  Google Scholar 

  31. American College of, O., Gynecologists, and P. Task Force on Hypertension in, Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122–31.

    Article  Google Scholar 

  32. Magee LA, et al. Do labetalol and methyldopa have different effects on pregnancy outcome analysis of data from the control of hypertension in pregnancy study (CHIPS) trial. BJOG. 2016;123(7):1143–51.

    Article  CAS  Google Scholar 

  33. Xie RH, et al. Association between labetalol use for hypertension in pregnancy and adverse infant outcomes. Eur J Obstet Gynecol Reprod Biol. 2014;175:124–8.

    Article  CAS  Google Scholar 

  34. Cooper WO, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354(23):2443–51.

    Article  CAS  Google Scholar 

  35. Bates SM, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e691S–736S.

    Article  CAS  Google Scholar 

  36. American Diabetes Association. 12. Management of diabetes in pregnancy. Diabetes Care. 2016;39(Suppl 1):S94–8.

    Google Scholar 

  37. Stover J. Nutritional management of pregnancy in chronic kidney disease. Adv Chronic Kidney Dis. 2007;14(2):212–4.

    Article  Google Scholar 

  38. Piccoli GB, et al. Association of low-protein supplemented diets with fetal growth in pregnant women with CKD. Clin J Am Soc Nephrol. 2014;9(5):864–73.

    Article  Google Scholar 

  39. Piccoli GB, et al. Pregnancy and chronic kidney disease: a challenge in all CKD stages. Clin J Am Soc Nephrol. 2010;5(5):844–55.

    Article  Google Scholar 

  40. National Center for. Clinical medical research on renal disease, guidelines for pregnancy management in patients with chronic kidney disease. Natl J Med China. 2017;97(12):3604–11.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Kidney Disease, Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China

    Weichun He

Authors
  1. Weichun He
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Weichun He .

Editor information

Editors and Affiliations

  1. Centre for Kidney Disease, Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China

    Junwei Yang

  2. Centre for Kidney Disease, Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China

    Weichun He

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

He, W. (2020). Pregnancy in Chronic Kidney Disease. In: Yang, J., He, W. (eds) Chronic Kidney Disease. Springer, Singapore. https://doi.org/10.1007/978-981-32-9131-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-981-32-9131-7_5

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-32-9130-0

  • Online ISBN: 978-981-32-9131-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation